BioVie Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BioVie Inc BIVI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 8.06 19:00:00
Open Price Low Price High Price Close Price Previous Close
Bid Price Ask Price Spread News
7.50 8.06 0.56 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 8.06 USD

BioVie Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 112.16M 13.92M 9.44M $ - $ - -7.67 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 44.90k 8.10%

more financials information »

BioVie News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIVI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.628.297.507.9714,6690.445.77%
1 Month8.008.537.508.0415,9860.060.75%
3 Months10.5012.007.509.3433,823-2.44-23.24%
6 Months10.5012.007.509.3433,823-2.44-23.24%
1 Year10.5012.007.509.3433,823-2.44-23.24%
3 Years10.5012.007.509.3433,823-2.44-23.24%
5 Years10.5012.007.509.3433,823-2.44-23.24%

BioVie Description

BioVie Inc is active in the healthcare domain in the United States. The company is a development stage enterprise engaged in the discovery, development, and commercialization of a therapy targeting ascites due to liver cirrhosis. Its therapy BIV201 is based on a drug that is approved in about 40 countries to treat related complications of liver cirrhosis. BioVie is developing BIV201 for alleviating the portal hypertension and correcting splanchnic vasodilation, thereby increasing effective blood volume and reducing the signals to the kidneys to retain excess salt and water.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.